‌

US Patent 11220500 Crystalline form of Valbenazine dibesylate

Patent 11220500 was granted and assigned to Apotex on January, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Apotex

Current Assignee

Apotex

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11220500

Patent Inventor Names

Mohammed Abdul Raheem0

Mohamed Ibrahim Zaki0

Yajun Zhao0

Stuart P. Green0

Allan W. Rey0

Jenny L. Gerster0

Minh T. N. Nguyen0

Date of Patent

January 11, 2022

Patent Application Number

16718841

Date Filed

December 18, 2019

Patent Primary Examiner

‌

Nizal S Chandrakumar

Patent abstract

The present invention provides a novel crystalline form of Valbenazine dibesylate, Valbenazine dibesylate Form APO-I, compositions and processes for the preparation thereof, and the use of this crystalline form in the treatment of hyperkinetic disorders, including tardive dyskinesia.